Pediatric DRV/r (pDRV/r) FAQs
This document is meant to answer some of the most common questions that surround pediatric darunavir/ritonavir 120/20mg (pDRV/r) - a new...
top of page
A framework to support new product introduction in national health systems
Resource Library
Sep 6, 2023
Pediatric DRV/r (pDRV/r) Product Profile
This product profile provides a clinical overview of the best-in-class protease inhibitor (PI) formulated in a fixed-dose combination...
152
Jun 5, 2023
Pediatric ALD (pALD) FAQs
This document is meant to answer some of the most common questions surround the fixed-dose combination of pediatric...
246
May 30, 2023
pALD Product Profile
This product profile provides a clinical overview of the fixed-dose combination of pediatric abacavir/lamivudine/ dolutegravir 60/30/5 mg...
1,032
Mar 16, 2022
CHAI DRV/r 2L Product Profile
A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
173
Oct 11, 2021
CHAI Pediatric DTG Product Profile
This product profile provides a clinical overview of pediatric DTG, market updates and implementation considerations, and provides...
142
Aug 1, 2018
TLD Resources
CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...
73
Jul 31, 2017
CHAI TLD Product Profile
This presentation provides a broad overview of the benefits of DTG-containing regimens, the advantages of fixed-dose combination ARVs,...
15
Jan 1, 2017
CHAI Pediatric LPV/r Oral Pellets Product Profile
This presentation provides a broad overview of pediatric LPV/r oral pellets, guidance on administration, and key considerations for...
8
bottom of page